Document Type : Review Articles
Authors
1
Ksa, Ministry of health, Jeddah First health cluster , Executive Managment Operation
2
Ksa, Ministry of health
3
Ksa, Ministry of health, Branch of the Ministry of health in Riyadh Region
4
Ksa, Ministry of health, Mansora primary health center
5
Ksa, Ministry of health, Faisaliah primary health center
6
Ksa, Ministry of health, Prince Mohammed Bin Nasser Hospital
7
Ksa, Ministry of health, Pharmacist in the public Health Department Riyadh
8
Ksa, Ministry of health, Riyadh
9
Ksa, Ministry of health, Al Amajiya Health Center
10
Ksa, Ministry of health, Jazan Health Complex
11
Ksa, Ministry of health, Sabya General Hospital Jazan
12
Ksa, Ministry of health, king saud hospital
13
Ksa, Ministry of health, Branch of the Ministry of Health in Asir Region
14
Ksa, Ministry of health, King Abdulaziz Hospital Jeddah
15
Ksa, Ministry of health, Hotat Bani Tamim Hospital
Abstract
Background:
Targeted drug delivery systems have transformed modern therapeutics by enabling precise delivery of drugs to specific sites, thereby reducing systemic toxicity. Smart polymers, with their unique ability to respond to environmental and biological stimuli, have emerged as innovative materials for developing responsive therapeutic systems. These polymers enable controlled drug release in response to triggers such as pH, temperature, enzymatic activity, and light, providing a significant advantage over conventional delivery systems. Despite their potential, challenges such as scalability, biocompatibility, and regulatory hurdles remain barriers to widespread clinical adoption.
Aim:
This paper aims to explore the role of smart polymers in advancing targeted drug delivery systems, with a focus on their responsive mechanisms, therapeutic applications, and future potential.
Methods:
The paper synthesizes findings from peer-reviewed studies and experimental data to evaluate the design, function, and clinical applications of smart polymers. Key responsive mechanisms and their implementation in polymer-based systems such as hydrogels, micelles, and nanocarriers are analyzed. Comparative evaluations with non-responsive delivery systems and case studies of clinical applications are included.
Results:
Smart polymers demonstrate significant improvements in targeted delivery, including enhanced drug bioavailability, reduced systemic toxicity, and improved therapeutic outcomes. Successful applications are highlighted in oncology, diabetes management, and neurodegenerative disease treatments. Case studies reveal promising clinical trial outcomes, but challenges in cost, production, and regulatory compliance remain.
Conclusion:
Smart polymers represent a transformative advancement in drug delivery, providing responsive, patient-specific therapeutic solutions. Addressing current challenges through interdisciplinary innovation and integration with emerging technologies such as nanotechnology and artificial intelligence could unlock their full potential, improving the efficacy and accessibility of future therapies.
Keywords
Main Subjects
)
View on SCiNiTO